| Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years | Anemia Iron-deficiency | 1 Month to 17 Years | Enrolling |
| A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) (RELIANCE-II) | Major Depressive Disorder | 18 Years to 65 Years | Enrolling |
| Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) | Irritable Bowel Syndrome With Constipation | 6 Years to 17 Years | Enrolling |
| Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma | Asthma | 12 Years to 80 Years | Enrolling |
| A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity Disorder | Attention-Deficit/Hyperactivity Disorder | 13 Years to 17 Years | Enrolling |
| Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies | Dyslipidemias, High Cholesterol, Hypercholesterolemia, Familial Hypercholesterolemia, Atherosclerotic Cardiovascular Disease | 18 Years and older | Enrolling |
| Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD | Post-traumatic stress disorder
(PTSD) | 18 Years to 65 Years | Enrolling |
| Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension | Hypertension (Resistant) | 18 Years to 99 Years | Enrolling
|
| A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. | Chronic Obstructive Pulmonary Disease | 40 Years and older | Enrolling |
| A Study of CIN-107 in Patients With Uncontrolled Hypertension Receiving 1 Antihypertensive Agent | Hypertenstion (Uncontrolled) | 18 and older | Enrolling |
The Center for Clinical Trials 